AndrewHLimperMD
Pulmonology • Rochester, MNCritical Care Medicine, Pleural Disease
Professor, Internal Medicine, Mayo Medical School
Dr. Limper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511- Is this information wrong?
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1989- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1984 - 1986
University of Illinois College of MedicineClass of 1984
Certifications & Licensure
MN State Medical License 1985 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2001
Clinical Trials
- Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
Publications & Presentations
PubMed
- 1 citationsThe intestinal commensal fungus Wallemia mellicola enhances asthma in mice through Dectin-2.Amjad N Kanj, Irene Riestra Guiance, Theodore J Kottom, Kyle J Schaefbauer, Malay Choudhury, Andrew H Limper, Joseph H Skalski> ;Medical Mycology. 2024 Jan 27
- 2 citationsClonal Somatic Mutations in Chronic Lung Diseases Are Associated with Reduced Lung Function.Jeong H Yun, M A Wasay Khan, Auyon Ghosh, Brian D Hobbs, Peter J Castaldi, Craig P Hersh, Peter G Miller, Carlyne D Cool, Frank Sciurba, Lucas Barwick, Andrew H Limper...> ;American Journal of Respiratory and Critical Care Medicine. 2023 Dec 1
- Real-world cohort evaluation of the impact of the antifibrotics in patients with idiopathic pulmonary fibrosis.Timothy M Dempsey, Viengneesee Thao, David A Helfinstine Jr, Yu-Hui H Chang, Lindsey Sangaralingham, Andrew H Limper> ;The European Respiratory Journal. 2023 Oct 1
- Join now to see all
Abstracts/Posters
- Incidence and Outcomes of Pneumocystis pneumonia When Utilizing PCR-Based Diagnosis in Patients with Hodgkin Lymphoma Receiving Intensive ChemotherapyAndrew H Limper, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Other
- Pulmonary toxicity associated with antineoplastic therapy: Cytotoxic agentsLimper AH, Maldonado F, Jett JR
http://www.uptodate.com/contents/pulmonary-toxicity-associated-with-antineoplastic-therapy-cytotoxic
UpToDate, Wolters Kluwer Health - 2013-03-28 - Pulmonary toxicity associated with antineoplastic therapy: Molecularly targeted agentsLimper AH, Maldonado F, Jett JR
http://www.uptodate.com/contents/pulmonary-toxicity-associated-with-antineoplastic-therapy-molecular
UpToDate, Wolters Kluwer Health - 2013-02-27 - Pulmonary toxicity associated with systemic antineoplastic therapy: Clinical presentation, diagnosis, and treatmentLimper AH, Maldonado F, Jett JR
http://www.uptodate.com/contents/pulmonary-toxicity-associated-with-systemic-antineoplastic-therapy-
UpToDate, Wolters Kluwer Health - 2012-03-29 - Join now to see all
Press Mentions
Fungal Infections Are Becoming More Frequent. Why Isn't There a Vaccine?February 10th, 2023- Fungal Infections Are Becoming More Common. Why Isn’t There a Vaccine?February 10th, 2023
- New Automated Screening Tool Could Mean EarliSeptember 29th, 2022
- Join now to see all
Grant Support
- Cholesterol And Sphingolipid Perturbation Of Membrane Traffic In Human DiseaseNational Institute Of General Medical Sciences2010–2011
- Pneumocystis Carinii: Macrophage And Epithelial ActivationNational Heart, Lung, And Blood Institute2008–2011
- Control Of The Pneumocystis Carinii Life CycleNational Heart, Lung, And Blood Institute2004–2008
- Pneumocystis Carinii: Macrophage &Epithelial ActivationNational Heart, Lung, And Blood Institute2004–2007
- Nhlbi Respiration Biology Research Training GrantNational Heart, Lung, And Blood Institute2004–2007
- Pneumocystis Carinii: Macrophage &Epithelial ActivationNational Heart, Lung, And Blood Institute2003
- Nhlbi Respiration Biology Research Training GrantNational Heart, Lung, And Blood Institute2003
- Control Of The Pneumocystis Carinii Cell CycleNational Heart, Lung, And Blood Institute1995–2003
- Pneumocystis Carinii--Macrophage Uptake And ActivationNational Heart, Lung, And Blood Institute1998–2002
- Nhlbi Respiratory Biology Research Training GrantNational Heart, Lung, And Blood Institute1998–2002
- Surfactant Protein D In Pneumocystis/Host InteractionNational Heart, Lung, And Blood Institute1997–1999
- Pneumocystis Carinii--Macrophage Uptake And ActivationNational Institute Of Allergy And Infectious Diseases1993–1997
Hospital Affiliations
Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
